A role of nerve growth factor in oligodendrocyte growth and differentiation of EAE affected rats

Archives Italiennes de Biologie

Volumn 136, Issue 4, 1998, Pages 247-256

  Aloe, L ^a   Micera, A ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN VENTRICLE; CEREBROSPINAL FLUID; EMBRYO DEVELOPMENT; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NERVE INJURY; NONHUMAN; OLIGODENDROGLIA; RAT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CEREBRAL VENTRICLES; CORPUS CALLOSUM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IODINE RADIOISOTOPES; MALE; NERVE GROWTH FACTORS; OLFACTORY BULB; OLIGODENDROGLIA; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0031794098     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ALOE, L., BRACCI-LAUDIERO, L., Bonini, S. and MANNT, L. The expanding role of Nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy, 52: 883-994, 1997.
2. ALOE, L., SKAPER, S.D., LEON, A. and LEVI-MONTALCINI, R. Nerve growth factor and autoimmune diseases. Autoimmunity, 19: 141-150, 1994.
3. ALTHAUS, H.H., KLOPPNER, S., SCHMIDT-SCHULTZ T. and SCHWARTZ, P. Nerve growth factor induces proliferation and enhances fibre regeneration in oligodendrocytes isolated from adult pig brain. Neurosci. Lett., 135: 219-223, 1992.
4. BOCCHINI, G. and ANGELETTI, P.U. The nerve growth factor: purification as a 30,000 molecular-weight protein. Proc Natl. Acad. Sci. USA, 64: 787-794, 1969.
5. BRACCI-LAUDIERO, L., ALOE, L., LEVI-MONTALCINI, R., BUTTINELLI, C., SCHILTER, D., GILLESSEN, S. and OTTEN, U. Multiple sclerosis patients express increased levels of b-nerve growth factor in cerebrospinal fluid. Neurosci Lett., 147: 9-12, 1992.
6. CALZÀ, L., GIARDINO, L., POZZA, M., BETTELLI, C., MICERA, A. and ALOE, L. Proliferation and phenotype regulation in the subventricular zone during experimental allergic enephalomyelitis: in vivo evidence of a role for nerve growth factor. Proc. Natl. Acad. Sci. USA, 95: 3209-3214, 1998.
7. CALZÀ, L., GIARDINO, L., POZZA, M., MICERA, A. and ALOE, L. Time-course of NGF, CRH and NOS isoforms and their possible role in the development of inflammatory response in EAE. Proc. Natl. Acad. Sci. USA, 94: 3368-3373, 1997.
8. COHEN, R.I., MARMUR, R., NORTON, W.T., MEHLER, M.F. and KESSLER, J.A. 1996. Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J. Neurosci., 16: 64336442.
9. DE SIMONE, R., MICERA, A., TIRASSA, P. and ALOE, L. mRNA for NGF and p75 in the central nervous system of rats affected by experimental allergic encephalomyelitis. Exp. Neurol. Appl. Neurobiol., 22: 54-59, 1996.
10. DIAZ-VILLASLADA, P., BARTKE, I., UNGER, J., FISHER, S., ROSENBERG, D., GENAIN, P.C. and HAUSER, S.L. Recombinant human NGF prevents autoimmune demyelination in marmosets. Neurology, 48, S15.001, 1997.
11. GOLDMAN, J. E. Regulation of oligodendrocyte differentiation. TINS, 15: 359-362, 1994.
12. HEFTI, F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transection. J. Neurosci., 6: 2155-2162, 1986.
13. HEUMANN, R., KORSHING, S., BANDTLOW, C. and THOENEN, H. Changes of nerve growth factor syntesis in non neuronal cells in response to sciatic nerve transection. J. Cell. Biol., 104: 1623-1631, 1987.
14. LADIWALA, U., LACHANCE, C., SIUMONEAU, S.J.J., BHAKKAR, A., BARKER, P.A. and ANTEL, J.P. p75neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J. Neurosci., 18: 1297-1304, 1998.
15. LAPCHACK, P.A. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol., 124: 1620, 1993.
16. LEVI-MONTALCINI, R. The nerve growth factor 35 years later. Science, 237: 11541162, 1987.
17. LEVI-MONTALCINI, R. and ALOE, L. Differentiating effects of murine ngf in the peripheral and central nervous systems of Xenopus laevis tadpoles. Proc. Natl. Acad. Sci., USA, 82: 7111-7115, 1985.
18. LEVI-MONTALCINI, R., ALOE, L. and ALLEVA E. A role for nerve growth factor in nervous, endocrine and immune systems. Progr. Neuro Endocrin Immunol., 3: 1-10, 1990.
19. Lu, X. and RICHARDSON, P.M. Inflammation near the nerve cell body enhances axonal regeneration. J. Neurosci., 11: 972-978, 1991.
20. LUSKIN, M.B. Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron, 11: 173-189, 1993.
21. Mc KINNON, R.D., MATSUT, T., DUBOIS-DALCQ, M. and AARONSON, S.A. FGF modulates the PDGF-driven pathway of oligodendrocyte development.Neuron, 5: 603-614, 1990.
22. MEAKIN, S.O. and SHOOTER, E.M. The nerve growth factor family of receptors. Trends Neurosci., 15: 323-331, 1992.
23. MICERA, A., DE SIMONE, R. and ALOE, L. Elevated levels of perve growth factor in the thalamus and spinal cord of rats affected by experimental allergic encephalomyelitis. Arch. Ital. Biol., 133: 131-142, 1995.
24. MICERA A., VIGNETI, E. and AEOE, L. Changes of NGF presence in non neuronal cells in response to experimental allergic encephalomyelitis in Lewis rats. Exp. Neurol., in press, 1998.
25. MILLER, R.H. Oligodendrocyte origins. TINS, 19: 92-96, 1996.
26. NOBLE, M., MURRAY, K., STROOBANT, P., WATERFIELD, M.D. and RIDDLE, P. Platelet-derived growth factor promotes division and mitility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cells. Nature, 333: 560-562, 1988.
27. OZAWA, K., SUCHANEK, G., BREITSCHOPF, H., BRUCK, W., BUDKA, H., JELLINGER, K. and LASSMANN, H. Pattems of oligodendroglia pathology in multiple sclerosis. Brain, 117: 1311-1322, 1994.
28. PATERSON, P.Y. Experimental autoimmune (allergic) encephalomyelitis: induction, pathogenesis and suppression. PP 179-213. In: MIESCHER, P.A. and MULLER EBERHARD H.J. (Eds.), Texbook of Immunopathology., New York, Grune and Stratton, 1976.
29. PAXINOS, G. and WATSON, C The Rat Brain in Stereotaxic Coordinates. Second Edition. Australia, Academic Press, 1986.
30. PRINEAS J.W. Neuropathology of Multiple Sclerosis. PP 213-257. In: VINKEN, P.J., BRUYN, G. W., and KLAWANS, H.L. (Eds.). Handbook of Clinical Neurology. Amsterdam, Elsevier, 1985.
31. RAINE, C.S. EAE and related conditions. PP 429-466. In: KOETEIER J.C. (Ed.), Handbook of Clinical Neurology. Vol.3. Demyelinating Diseases. Amsterdam, Elsevier, 1985.
32. SANETO, R.P. and DEVELLIS, J. Characterization of coltured rat oligodendrocytes proliferating in a serum free, chemically defined medium. Proc. Natl. Acad. Sci., USA, 82: 3509-3513, 1985.
33. SCOLDING, N.J., ZAJICEK, J.P., WOOD, N. and COMPSTON, D.A.S. The pathogenesis of demyelinating disease. Progr. Neurobiol., 43: 143-173, 1994.
34. SHERWOOD, N.M. and TIMIRES, P.S. A Stereotaxic Atlas of the Developing Rat Brain. Berkeley, Los Angeles, London, University of California, 1970.
35. THOENEN, H. and BARDE, Y.A. Physiology of nerve growth factor. Physiol Rev., 1284-1335, 1980.